Funded Startups in Paterna
Five recently dated rounds are listed for Paterna, Comunidad Valenciana, spanning 2021-03-25 (Kenmei Technologies) to 2026-06-30 (iPremom).
Five recently dated rounds are listed for Paterna, Comunidad Valenciana, spanning 2021-03-25 (Kenmei Technologies) to 2026-06-30 (iPremom). A single disclosed round stands out: Highlight Therapeutics raised $18M on 2025-09-17, and the next-largest disclosed amounts are $16M (Matteco, 2024-10-23) and $3M (iPremom, 2026-06-30), so $18M sits far above the rest. The distribution also clusters into two time windows: two entries fall in 2021 (Kenmei Technologies on 2021-03-25 and Bionline on 2021-04-26), while three entries land between 2024-10-23 and 2026-06-30 (Matteco, iPremom, and Highlight Therapeutics).
Sector mix is concentrated as well: Biotechnology appears in two of the five entries (iPremom and Highlight Therapeutics), while “Venture - Series Unknown” shows up in two entries (Highlight Therapeutics and Bionline) alongside one “Series A” (Matteco) and one “Series A” (Kenmei Technologies). The smallest disclosed amount in the set is $900K for Bionline (2021-04-26), making it a low-end outlier relative to the $2M–$18M disclosed range.
Most recent rounds
5 shownRelated listings
Frequently asked
What’s the largest disclosed round in Paterna in this list, and how does it compare with the others?
Highlight Therapeutics’ $18M (2025-09-17) is the clear top disclosed amount, with the next-largest being Matteco’s $16M (2024-10-23). iPremom’s $3M (2026-06-30) and Kenmei Technologies’ $2M (2021-03-25) fall well below those two, and Bionline’s $900K (2021-04-26) is the low end.
Do these rounds cluster into specific date windows rather than spreading evenly?
Yes. Two rounds sit near each other in early 2021—Kenmei Technologies at $2M (2021-03-25) and Bionline at $900K (2021-04-26)—and a later cluster spans 2024-10-23 through 2026-06-30 with Matteco ($16M, 2024-10-23), Highlight Therapeutics ($18M, 2025-09-17), and iPremom ($3M, 2026-06-30).
Are any sectors over-represented among these five Paterna entries?
Biotechnology accounts for 2 of the 5 entries (iPremom and Highlight Therapeutics). The remaining single entries each cover Information Technology (Matteco), Data and Analytics (Bionline), and Manufacturing (Kenmei Technologies), so no other sector reaches the same frequency in this slice.
Which entries are most recent within the set, and how concentrated are the latest closings?
The most recent date shown is iPremom on 2026-06-30 with a $3M round. The next-latest is Highlight Therapeutics on 2025-09-17 ($18M); all remaining entries are at least a year older (Matteco 2024-10-23 at $16M, then 2021 dates for Bionline and Kenmei Technologies).
Is there a stage/series pattern that dominates this list, or do stages vary widely?
“Series A” appears twice (Matteco at $16M on 2024-10-23; Kenmei Technologies at $2M on 2021-03-25), while “Venture - Series Unknown” appears twice (Highlight Therapeutics at $18M on 2025-09-17; Bionline at $900K on 2021-04-26). The remaining entry uses “Series Unknown” (iPremom at $3M on 2026-06-30), so stages are split between identifiable Series A and two entries with an unknown classification.
Are there outliers worth flagging in disclosed amounts or sector mix?
Yes on both dimensions. By amount, Bionline’s $900K (2021-04-26) is substantially below the rest, which range from $2M (Kenmei Technologies) up to $18M (Highlight Therapeutics). By sector, Biotechnology’s two entries include both the top disclosed $18M and a mid-tier $3M ($iPremom on 2026-06-30), while the non-biotech entries are concentrated around $2M–$16M (Kenmei Technologies, Bionline, Matteco).
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.